Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor

Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor

Primary hepatic neuroendocrine tumor (PHNET) is rare liver cancer and related prognostic factors are unclear. The aim of this study was to analyze the prognostic risk factors of patients with PHNETs and establish an assessment model for prognosis. The clinical information of 539 patients with PHNETs...

Full description

Bibliographic Details
Main Authors: Jianyang Lin, Xiang Li, Xin Ding, Zhihong Chen, Yinyan Wu, Kun Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Medicine
Subjects:
competing risk model
decision curve analysis
nomogram
primary hepatic neuroendocrine tumor
surveillance
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.960235/full

Similar Items

Similar Items